Open Beta
TREN
MetriLume
TREN

US marketsRKDA

SEC-sourced researchBeta

RKDA

Arcadia Biosciences, Inc.

Company comparison ↗

Data passport

CIK
0001469443
Exchange
Nasdaq
Business activity
— · SIC 1311
Financial inputs
6/6
Filing date
Sep 30, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 5,045,000.0000 USD; December 2025: 4,858,000.0000 USD5M USD0 USD0December 2024December 2025
RKDA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20245,045,000.0000Mar 26, 2026
December 20254,858,000.0000Mar 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20254,858,000.0000-2,339,000.0000-4,739,000.00006,546,000.00002,406,000.0000Mar 26, 2026
December 20245,045,000.0000-7,038,000.0000-9,627,000.000013,517,000.00007,294,000.0000Mar 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$4.86MDecember 2025Mar 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$5.05MDecember 2024Mar 26, 202610-K
Net incomeNetIncomeLoss-$2.34MDecember 2025Mar 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$4.74MDecember 2025Mar 26, 202610-K
Total assetsAssets$6.55MDecember 2025Mar 26, 202610-K
Total liabilitiesLiabilities$2.41MDecember 2025Mar 26, 202610-K

New filings

Explore methodology ↗